55
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Treatment outcomes in patients with Ewing sarcoma of the spine in a resource-challenged setting: 17-year experience from a single center in India

, , , , , , , , , ORCID Icon, , , & show all
Pages 211-223 | Received 11 Sep 2023, Accepted 14 Dec 2023, Published online: 08 Jan 2024

References

  • Biswas B, Bakhshi S. Management of Ewing sarcoma family of tumors: current scenario and unmet need. World J Orthop. 2016;7(9):527–538. doi:10.5312/wjo.v7.i9.527.
  • Indelicato DJ, Keole SR, Shahlaee AH, et al. Spinal and paraspinal Ewing tumors. Int J Radiat Oncol Biol Phys. 2010;76(5):1463–1471. doi:10.1016/j.ijrobp.2009.03.042.
  • Dahlin DC, Coventry MB, Scanlon PW. Ewing’s sarcoma: a critical analysis of 165 cases. JBJS. 1961;43(2):185–192. doi:10.2106/00004623-196143020-00004.
  • Grubb MR, Currier BL, Pritchard DJ, Ebersold MJ. Primary Ewing’s sarcoma of the spine. Spine (Phila Pa 1976). 1994;19(3):309–313. doi:10.1097/00007632-199402000-00009.
  • Venkateswaran L, Rodriguez-Galindo C, Merchant TE, Poquette CA, Rao BN, Pappo AS. Primary Ewing tumor of the vertebrae: clinical characteristics, prognostic factors, and outcome. Med Pediatr Oncol. 2001;37(1):30–35. doi:10.1002/mpo.1159.
  • Sharafuddin MJA, Haddad FS, Hitchon PW, Haddad SF, El-Khoury GY. Treatment options in primary Ewing’s sarcoma of the spine: report of seven cases and review of the literature. Neurosurgery. 1992;30(4):610. doi:10.1227/00006123-199204000-00025.
  • Villas C, Julian MS. Ewing’s tumor of the spine: report on seven cases including one with a 10-year follow-up. Eur Spine J. 1996;5(6):412–417. doi:10.1007/BF00301970.
  • Biswas B, Rastogi S, Khan SAS, et al. Developing a prognostic model for localized Ewing sarcoma family of tumors: a single institutional experience of 224 cases treated with uniform chemotherapy protocol. J Surg Oncol. 2015;111(6):683–689. doi:10.1002/jso.23861.
  • Biswas B, Rastogi S, Khan SA, et al. Hypoalbuminaemia is an independent predictor of poor outcome in metastatic Ewing’s sarcoma family of tumours: a single institutional experience of 150 cases treated with uniform chemotherapy protocol. Clin Oncol (R Coll Radiol). 2014;26(11):722–729. doi:10.1016/j.clon.2014.05.006.
  • Prabu R, Thulkar S, Chand Sharma M, Mohanti BK, Dhawan D, Bakhshi S. PNET Spine: morbid and mortal, but ignored till late. J Pediatr Hematol Oncol. 2012;34(4):e164–e169. doi:10.1097/MPH.0b013e31824414b2.
  • Khattry N, Thulkar S, Das A, Khan SA, Bakhshi S. Spinal tuberculosis mimicking malignancy: atypical imaging features. Indian J Pediatr. 2007;74(3):297–298. doi:10.1007/s12098-007-0049-3.
  • Grier HE, Krailo MD, Tarbell NJ, et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing’s sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med. 2003;348(8):694–701. doi:10.1056/NEJMoa020890.
  • Womer RB, West DC, Krailo MD, et al. Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the children’s oncology group. J Clin Oncol. 2012;30(33):4148–4154. doi:10.1200/JCO.2011.41.5703.
  • Biswas B, Agarwala S, Rastogi S, et al. High burden of metastases and poor outcome in pelvic PNET. Pediatr Blood Cancer. 2013;60(9):E97–E99. doi:10.1002/pbc.24552.
  • Biswas B, Agarwala S, Shukla NK, et al. Evaluation of outcome and prognostic factors in thoracic primitive neuroectodermal tumor: a study of 84 cases. Ann Thorac Surg. 2013;96(6):2006–2014. doi:10.1016/j.athoracsur.2013.06.062.
  • Biswas B, Rastogi S, Khan SA, et al. Outcomes and prognostic factors for Ewing-family tumors of the extremities. J Bone Joint Surg Am. 2014;96(10):841–849. doi:10.2106/JBJS.M.00411.
  • Ilaslan H, Sundaram M, Unni KK, Dekutoski MB. Primary Ewing’s sarcoma of the vertebral column. Skeletal Radiol. 2004;33(9):506–513. doi:10.1007/s00256-004-0810-x.
  • Hesla AC, Bruland ØS, Jebsen N, Styring E, Eriksson S, Tsagozis P. Ewing sarcoma of the mobile spine; predictive factors for survival, neurological function and local control. a Scandinavian sarcoma group study with a mean follow-up of 12 years. J Bone Oncol. 2019;14:100216. doi:10.1016/j.jbo.2018.100216.
  • Schuck A, Ahrens S, Schorlemer IV, et al. Radiotherapy in Ewing tumors of the vertebrae: Treatment results and local relapse analysis of the CESS 81/86 and EICESS 92 trials. Int J Radiat Oncol Biol Phys. 2005;63(5):1562–1567. doi:10.1016/j.ijrobp.2005.05.036.
  • Zhang J, Huang Y, Lu J, et al. Impact of first-line treatment on outcomes of Ewing sarcoma of the spine. Am J Cancer Res. 2018;8(7):1262–1272.
  • Biswas B, Thakar A, Mohanti B, Vishnubhatla S, Bakhshi S. Prognostic factors in head and neck Ewing sarcoma family of tumors. Laryngoscope. 2015;125(3):E112–7. doi:10.1002/lary.24985.
  • Sasi A, Ganguly S, Biswas B, et al. Development and validation of a prognostic score at baseline diagnosis for Ewing sarcoma family of tumors: a retrospective single institution analysis of 860 patients. Am J Transl Res. 2022;14(2):927–927.
  • Bakhshi S, Meel R, Naqvi SGH, et al. Therapy and outcome of orbital primitive neuroectodermal tumor. Pediatr Blood Cancer. 2009;52(4):544–547. doi:10.1002/pbc.21902.
  • Sasi A, Ganguly S, Biswas B, et al. Determinants and impact of diagnostic interval in bone sarcomas: A retrospective cohort study. Pediatr Blood Cancer. 2023;70(3):e30135. doi:10.1002/pbc.30135.
  • Bacci G, Boriani S, Balladelli A, et al. Treatment of nonmetastatic Ewing’s sarcoma family tumors of the spine and sacrum: the experience from a single institution. Eur Spine J. 2009;18(8):1091–1095. doi:10.1007/s00586-009-0921-0.
  • Garg A, Iyer H, Jindal V, et al. Evaluation of delays during diagnosis and management of lung cancer in India: A prospective observational study. Eur J Cancer Care (Engl). 2022;31(5):e13621. doi:10.1111/ecc.13621.
  • Masamba LPL, Jere Y, Brown ERS, Gorman DR. Tuberculosis diagnosis delaying treatment of cancer: experience from a new oncology unit in Blantyre, Malawi. J Glob Oncol. 2016;2(1):26–29. doi:10.1200/JGO.2015.000299.
  • Kumaran SP, Thippeswamy PB, Reddy BN, Neelakantan S, Viswamitra S. An institutional review of tuberculosis spine mimics on MR imaging: cases of mistaken identity. Neurol India. 2019;67(6):1408–1418. https://www.neurologyindia.com/article.asp?issn=0028-3886;year=2019;volume=67;issue=6;spage=1408;epage=1418;aulast=Kumaran;type=0
  • Marco RAW, Gentry JB, Rhines LD, et al. Ewing’s sarcoma of the mobile spine. Spine (Phila Pa 1976). 2005;30(7):769–773. doi:10.1097/01.brs.0000157755.17502.d6.
  • Arshi A, Sharim J, Park DY, et al. Prognostic determinants and treatment outcomes analysis of osteosarcoma and Ewing sarcoma of the spine. Spine J. 2017;17(5):645–655. doi:10.1016/j.spinee.2016.11.002.
  • Iqbal N, Shukla N, Deo S, et al. Prognostic factors affecting survival in metastatic soft tissue sarcoma: an analysis of 110 patients. Clin Transl Oncol. 2016;18(3):310–316. doi:10.1007/s12094-015-1369-9.
  • McLean TW, Stewart RM, Curley TP, et al. Hypoalbuminemia in children with cancer treated with chemotherapy. Pediatr Blood Cancer. 2020;67(2):e28065.
  • Aparicio J, Munárriz B, Pastor M, et al. Long-term follow-up and prognostic factors in Ewing’s sarcoma. A multivariate analysis of 116 patients from a single institution. Oncology. 1998;55(1):20–26. doi:10.1159/000011841.
  • Bahl A, Bakhshi S. Metronomic chemotherapy in progressive pediatric malignancies: old drugs in new package. Indian J Pediatr. 2012;79(12):1617–1622. doi:10.1007/s12098-012-0759-z.
  • Pramanik R, Bakhshi S. Metronomic therapy in pediatric oncology: A snapshot. Pediatr Blood Cancer. 2019;66(9):e27811. doi:10.1002/pbc.27811.
  • Grünewald TGP, Cidre-Aranaz F, Surdez D, et al. Ewing sarcoma. Nat Rev Dis Primer. 2018;4(1):5.
  • Patel A, Sharma MC, Mallick S, Patel M, Bakhshi S. Poor performance status, urban residence and female sex predict inferior survival in pediatric advanced stage mature B-NHL in an Indian tertiary care center. Pediatr Hematol Oncol. 2018;35(1):23–32. doi:10.1080/08880018.2018.1424279.
  • Bhatia KP, Ganguly S, Sasi A, et al. Sex disparity in childhood cancer in India: a multi-centre, individual patient data analysis. Lancet Oncol. 2023;24(1):54–63. doi:10.1016/S1470-2045(22)00688-X.
  • Ganguly S, Kinsey S, Bakhshi S. Childhood cancer in India. Cancer Epidemiol. 2021;71(Pt B):101679. doi:10.1016/j.canep.2020.101679.
  • Charest-Morin R, Dirks MS, Patel S, et al. Ewing sarcoma of the spine: prognostic variables for survival and local control in surgically treated patients. Spine (Phila Pa 1976). 2018;43(9):622–629. doi:10.1097/BRS.0000000000002386.
  • Xu K, Lou Y, Sun R, et al. Establishment of a nomogram-based model for predicting the prognostic value of inflammatory biomarkers and preoperative D-dimer level in spinal Ewing’s sarcoma family tumors: a retrospective study of 83 patients. World Neurosurg. 2019;121:e104–12–e112. doi:10.1016/j.wneu.2018.09.022.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.